Eosinophilic cationic protein as marker for response to antibody therapy in severe asthma.

Elisa FranceschiNora DrickJan Fuge Tobias WelteHendrik Suhling

Published in: ERJ open research (2022)

This study of the eosinophil cationic protein (ECP) as predictor of clinical response to biological therapy in severe asthma found that ECP is not useful in unselected patients but may have a role in those not exposed to oral corticosteroids. https://bit.ly/398RwEk.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
protein protein
prognostic factors
binding protein
amino acid
patient reported outcomes
cell therapy